Skip to main content
. Author manuscript; available in PMC: 2011 Jun 6.
Published in final edited form as: Mol Cancer Ther. 2010 May 25;9(6):1485–1488. doi: 10.1158/1535-7163.MCT-10-0156

Figure 1.

Figure 1

Representative blood cell counts prior to and after treatment with Anakinra. Hemoglobin (A), white blood cell count (B), and platelet count (C) improved after initiation of Anakinra. Arrow indicates when treatment with Anakinra was begun. Note: Initial drop in counts in 2005 corresponded with initiation of anti-IL-6 treatment. Also, patient underwent repeat plateletpheresis when platelet counts became elevated to more than 1,000 × 10 9/L.